Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/25/2006CN1850088A Pharmaceutical use of (2s-cis)-(+)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5H)-one for treating hepatitis
10/25/2006CN1850087A Effervescent tablet containing cefixime and its preparing method
10/25/2006CN1850086A Use of levo morpholine nidazole for preparing medicine for antiparasitic infection
10/25/2006CN1850085A Medicinal composition soft capsule and its preparing method
10/25/2006CN1850084A Medicinal composition soft capsule and its preparing method
10/25/2006CN1850083A Dispersible tablet for treating cold and its preparing process
10/25/2006CN1850082A Desoxyribose nucleic acid dual intercalating agent using methyl iso thiourea cation as linker
10/25/2006CN1850081A Use of 5-(3-aminobenzene)methyl nicotinate and its ahalogue as PI3K enzyme inhibitor
10/25/2006CN1850080A Oral dispersion domperidone coutrolled-release gel and its preparing method
10/25/2006CN1850079A Micro-powder dom peridone maleate medicinal composition and its preparing method
10/25/2006CN1850078A Anti-platelet aggregation medicinal injection and its preparing method
10/25/2006CN1850077A Lappaconitine hydrobromide dispersible tablet and its preparing method
10/25/2006CN1850076A Heat-sensitive gel containing matrine alkaloid and its preparing method
10/25/2006CN1850075A Medicinal use of matrine alkaloid for promoting digestive tract power
10/25/2006CN1850074A Method for preparing medicinal mixture containing amoxicillin sodium and potassium clavulanate
10/25/2006CN1850073A Medicinal composition containing ampicillin and its preparing method
10/25/2006CN1850072A Pharmaceutical use of alpha-(2,4-dichlorobenzyle)-1H-imidazole-1-ethanol for treating hepatitis
10/25/2006CN1850071A Bifendate solid dispersible, and its preparing method and low-release preparation containing same
10/25/2006CN1850070A Quercetin solid liposome nano particle preparation and its preparing method
10/25/2006CN1850069A Method for preparing Tengchasu dispersibletablet and its use
10/25/2006CN1850068A Medicinal composition for treating cardio-cerebral-vascular disease and its preparing method
10/25/2006CN1850067A Invivo oxyger-supply solution for injection, and its preparing method and use
10/25/2006CN1850066A Carboplatin venous emulsion and its preparing method
10/25/2006CN1850065A Use of oral conjugated linoleic acid and its derivative for increasing muscule and skin beauty
10/25/2006CN1850064A Preparation for relieving stress symptom
10/25/2006CN1850063A Composition containing fibrate drug and taurine
10/25/2006CN1850062A Fatty acid eye nano preparations for dry eye disease
10/25/2006CN1850061A Use of triethylene-tetramine as antitumour auxiliary drug
10/25/2006CN1850060A Anti-infection medicinal composition and its preparing method
10/25/2006CN1850059A Amlexanox oral membrane, and its preparing method
10/25/2006CN1850056A Taxotere lyophilized powder and its preparing method
10/25/2006CN1850055A Flunarizine hydrochloride lyophilized agent for injection and its preparing method
10/25/2006CN1850054A Vitamin A liposome artificial lacrimal eye drops
10/25/2006CN1850053A Chemotherapeutic emulsion for treating rectum cancer
10/25/2006CN1850047A Slow-release preparation containing beta-lactamase inhibitor and cephalosporin and its use
10/25/2006CN1850046A Slow-release preparation containing beta-lactamase inhibitor and its use
10/25/2006CN1850045A Slow-release preparation containing macrolides anti biotics
10/25/2006CN1850044A Slow-release injecta containing amino glucosides antibiotics and use thereof
10/25/2006CN1850043A Slow-release injecta containing platinums compound and its synergist
10/25/2006CN1850042A Anti-cancer slow-release preparation containing platinum medicines and its synergist
10/25/2006CN1850041A Anticancer medicine slow-release preparation containing platinum compound and its synergist
10/25/2006CN1850040A Loaded platinum drug and its synergist anticancer drug slow release agent
10/25/2006CN1850039A Compound platinum medicine slow-release preparation
10/25/2006CN1850036A Slow-release preparation containing quinolones antibiotics
10/25/2006CN1850035A Antibiotic slow-release preparation for local use
10/25/2006CN1850033A Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor
10/25/2006CN1850032A Amphotericin B nano preparation
10/25/2006CN1850021A Use of conjugated linoleic acid and its derivative for deep nourishing skin
10/25/2006CN1281753C Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses
10/25/2006CN1281752C Carcinoma of esophagus related gene-2 and use of coding protein thereof
10/25/2006CN1281744C Maltose-trehalose converting enzyme, and preparation and uses thereof
10/25/2006CN1281616C Compound extracted from hull and stem of yellow horn, extracting method and application
10/25/2006CN1281615C Novel 3.6-hemiketals from the class of 9a-azalides
10/25/2006CN1281608C New azo-indolyl derivatives
10/25/2006CN1281607C Quaternary ammonium salt compound of piperazine with pain relieving effect
10/25/2006CN1281606C Nitrogen-containing heterocyclic compound
10/25/2006CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006CN1281604C Substituted pyrazole compounds
10/25/2006CN1281603C Aminopyrrole compounds as antiinflammatory agents
10/25/2006CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006CN1281597C New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias
10/25/2006CN1281593C Immune regulation and biological therapeutic function of benzo-isoselenazole derivatives
10/25/2006CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006CN1281589C Preparation of 1-(6-methylpyridin-3-yl)-2-(4-methylsulfonyl-phenyl)ethanon
10/25/2006CN1281588C Novel intermediate for preparation of pyrazolopyrimidinones
10/25/2006CN1281585C Cyclic diamine compounds having fused-ring groups
10/25/2006CN1281570C Method for the purification of an alpha-hydroxy acid on an industrial scale
10/25/2006CN1281561C Compound with base skeleton of 1,6-methylene-[10]-annulene and use thereof
10/25/2006CN1281283C Procedure and composition of treatment and/or care of eye
10/25/2006CN1281274C 6-fluorobicyclo [3.1.0] hexane derivatives
10/25/2006CN1281271C Biological bacteria inhibitor
10/25/2006CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/25/2006CN1281261C Capsule for treating hypertension and coronary disease and its preparing method
10/25/2006CN1281258C Cosmetic use of hop and ornithine
10/25/2006CN1281242C Medicine for treating skin disease and preparation process
10/25/2006CN1281235C Medicine for treating hepatitis and its preparing process
10/25/2006CN1281232C Method for preparing compound licorice buccal tablet
10/25/2006CN1281231C External use medicinal composition for softening and dredging pyramis arteriosclerosis and its preparation method
10/25/2006CN1281230C Medicine composition for curing burn, scald and mucocutaneous ulcer
10/25/2006CN1281226C Pain-dispersing emplastrum
10/25/2006CN1281222C Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
10/25/2006CN1281219C Medicine for treating piles and its preparation method
10/25/2006CN1281216C Instant nutrition intensifying agent
10/25/2006CN1281215C The second purpose of Siberian solomonseal rhizome polysaccharide
10/25/2006CN1281214C Process for preparing ginkgo leaf extract powder injection
10/25/2006CN1281213C Process method for preparing sodium chloride injection of ginkgo leaf extract
10/25/2006CN1281212C General saponin of stem and leaf of American ginseng in Application of preparing medication for treating mycoarditis
10/25/2006CN1281211C Use of oxazolidinone in producing medication of treatment fof ocular infections of mammal
10/25/2006CN1281210C Application of Schisandrin-B in preparing medicine for treating tumor
10/24/2006US7126027 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
10/24/2006US7126026 For treatment of cardiovascular disorders; high yield; reducing, halogenating, hydrolyzing a 4-nitrophenylsulfur pentafluoride
10/24/2006US7126017 Method of reducing toxicity of retinoids
10/24/2006US7126015 Converting 2,3-O-isoproylideneglyceralde-hyde compound to a nitromethane derivative; transforming nitromethane derivative into a tetrahydrofuran derivative; intramolecular cyclisation to produce hexahydro-furo[2,3-b]furan-3-ol compound
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006US7126008 Carvedilol
10/24/2006US7126006 Substituted amine radical as building blocks; increases structural diversity
10/24/2006US7126004 Thiazoline acid derivatives
10/24/2006US7126001 Antiproliferative agents; antitumor agents